Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma
- 31 December 2012
- journal article
- research article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 57 (6), 1244-1250
- https://doi.org/10.1016/j.jhep.2012.07.017
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Radiographic Response to Locoregional Therapy in Hepatocellular Carcinoma Predicts Patient Survival TimesGastroenterology, 2011
- Drug-eluting bead loaded with doxorubicin versus conventional Lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinomaEuropean Journal of Gastroenterology & Hepatology, 2011
- Management of hepatocellular carcinoma: An updateHepatology, 2011
- Alpha-Fetoprotein Response After Locoregional Therapy for Hepatocellular Carcinoma: Oncologic Marker of Radiologic Response, Progression, and SurvivalJournal of Clinical Oncology, 2009
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V StudyCardioVascular and Interventional Radiology, 2009
- New Intra-arterial Drug Delivery System for the Treatment of Liver Cancer: Preclinical Assessment in a Rabbit Model of Liver CancerClinical Cancer Research, 2006
- Management of hepatocellular carcinomaHepatology, 2005
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001